SCHEMBL5054165

SCHEMBL5054165

Cn1nc(-c2cc3c(CNC4CCC(N)CC4)cccc3[nH]2)c2ccc(C(=O)O)cc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 3/20 0.37
▸ KDM4C Q9H3R0 3/20 0.36
▸ ITK Q08881 1/20 0.33
▸ SLC22A12 Q96S37 2/20 0.33
▸ SMYD3 Q9H7B4 4/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ DPP4 P27487 2/20 0.32
▸ SCN5A Q14524 1/20 0.32
▸ SCN9A Q15858 1/20 0.32
▸ HDAC3 O15379 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ HDAC1 Q13547 1/20 0.32
▸ HDAC7 Q8WUI4 1/20 0.32
▸ HDAC2 Q92769 1/20 0.32
▸ HDAC10 Q969S8 1/20 0.32
▸ HDAC11 Q96DB2 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5053947 0.87 SYK (0.36) SYKKDM4CSLC22A12ALDH1A1DPP4
SCHEMBL5058943 0.84 CHEK1 (0.38) KDM4C
SCHEMBL5054018 0.82 KDM4C (0.37) SYKKDM4CITKSLC22A12ALDH1A1
SCHEMBL5055543 0.82 KHK (0.38) SYKKDM4CITKSLC22A12
SCHEMBL5054001 0.81 KDM4C (0.36) SYKKDM4CITKSLC22A12ALDH1A1
SCHEMBL5054031 0.78 CHEK1 (0.44) KDM4CITKSLC22A12ALDH1A1
SCHEMBL5054169 0.76 CHEK1 (0.46) ITK
SCHEMBL27688840 0.73 ITK (0.40) ITK
SCHEMBL27688839 0.73 ITK (0.41) ITK
SCHEMBL5051829 0.72 CHEK1 (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004259-A1 Inhibitors of Checkpoint Kinases MERCK & CO., INC. 2008-01-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004259-A1 Inhibitors of Checkpoint Kinases CHEK1, CHEK2, BUB1B SYK 970/4885KDM4C 974/4885ITK 493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback